跳转至内容
Merck

In vitro to in vivo profiling: an easy idea for biowaiver study.

Acta poloniae pharmaceutica (2013-10-24)
Abdulhakim A A Khaled, Khalid Pervaiz, Sonia Khiljee, Sabiha Karim, Qurat-ul-Ain Shoaib, Ghulam Murtaza
摘要

The aim of this article was to assess and apply the in vitro to in vivo profiling (IVIVP), a new biowaiver approach, in designing a product with specific release pattern. The IVIVP was established by plotting the observed and predicted plasma drug concentrations. For IVIVP, convolution approach was employed to estimate plasma drug concentrations from in vitro dissolution profiles. The IVIVP for T1S exhibited a good correlation coefficient (R2 = 0.963) followed by the T2 (R2 = 0.682), T3 (R2 = 0.665), T1 (R2 = 0.616), and Mepresso (R2 = 0.345). Establishing an IVIVP, based on the convolution approach, can be more useful and practicable in the biowaiver studies, rather than present not useful practice of IVIVC estimated via deconvolution approach. This paper also elaborates that there is good correlation between the in vitro and in vivo profiles of the developed metoprolol tartrate formulations, particularly for T1S.

材料
货号
品牌
产品描述

Sigma-Aldrich
氧氯化锆 八水合物, reagent grade, 98%
Sigma-Aldrich
聚(甲基丙烯酸甲酯- co -甲基丙烯酸), average Mw ~34,000 by GPC, average Mn ~15,000 by GPC
Sigma-Aldrich
美托洛尔 (+)-酒石酸盐, ≥98% (titration), powder
USP
美托洛尔 (+)-酒石酸盐, United States Pharmacopeia (USP) Reference Standard
Supelco
美托洛尔 (+)-酒石酸盐, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
美托洛尔 酒石酸酯 溶液, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
美托洛尔 (+)-酒石酸盐, European Pharmacopoeia (EP) Reference Standard